日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2026/02/04 | 5,200 | 5,227 | 5,151 | 5,151 | -11 | -0.2% | 259,300 |
| 2026/02/03 | 5,200 | 5,229 | 5,162 | 5,162 | +20 | +0.4% | 255,000 |
| 2026/02/02 | 5,252 | 5,253 | 5,135 | 5,142 | -16 | -0.3% | 296,800 |
| 2026/01/30 | 5,151 | 5,195 | 5,095 | 5,158 | +47 | +0.9% | 298,000 |
| 2026/01/29 | 5,060 | 5,172 | 4,939 | 5,111 | -49 | -0.9% | 550,600 |
| 2026/01/28 | 5,200 | 5,246 | 5,143 | 5,160 | -86 | -1.6% | 412,100 |
| 2026/01/27 | 5,294 | 5,323 | 5,221 | 5,246 | -78 | -1.5% | 326,200 |
| 2026/01/26 | 5,331 | 5,368 | 5,290 | 5,324 | -107 | -2% | 305,700 |
| 2026/01/23 | 5,480 | 5,480 | 5,375 | 5,431 | -44 | -0.8% | 364,700 |
| 2026/01/22 | 5,435 | 5,480 | 5,416 | 5,475 | +73 | +1.4% | 279,800 |
| 2026/01/21 | 5,379 | 5,402 | 5,324 | 5,402 | +22 | +0.4% | 472,700 |
| 2026/01/20 | 5,363 | 5,433 | 5,324 | 5,380 | -10 | -0.2% | 256,300 |
| 2026/01/19 | 5,417 | 5,448 | 5,320 | 5,390 | -7 | -0.1% | 392,300 |
| 2026/01/16 | 5,530 | 5,600 | 5,355 | 5,397 | -215 | -3.8% | 512,500 |
| 2026/01/15 | 5,643 | 5,677 | 5,575 | 5,612 | -31 | -0.5% | 361,300 |
| 2026/01/14 | 5,710 | 5,720 | 5,605 | 5,643 | -41 | -0.7% | 401,700 |
| 2026/01/13 | 5,735 | 5,749 | 5,628 | 5,684 | +9 | +0.2% | 488,300 |
| 2026/01/09 | 5,690 | 5,761 | 5,549 | 5,675 | -78 | -1.4% | 633,300 |
| 2026/01/08 | 5,751 | 5,787 | 5,665 | 5,753 | +102 | +1.8% | 456,300 |
| 2026/01/07 | 5,630 | 5,717 | 5,602 | 5,651 | +21 | +0.4% | 413,500 |
| 2026/01/06 | 5,545 | 5,705 | 5,538 | 5,630 | +96 | +1.7% | 461,200 |
| 2026/01/05 | 5,650 | 5,678 | 5,505 | 5,534 | -116 | -2.1% | 523,600 |
| 2025/12/30 | 5,675 | 5,693 | 5,596 | 5,650 | +3 | +0.1% | 364,900 |
| 2025/12/29 | 5,790 | 5,791 | 5,624 | 5,647 | -116 | -2% | 353,000 |
| 2025/12/26 | 5,800 | 5,831 | 5,743 | 5,763 | +22 | +0.4% | 253,800 |
| 2025/12/25 | 5,850 | 5,855 | 5,691 | 5,741 | -49 | -0.8% | 272,600 |
| 2025/12/24 | 5,793 | 5,845 | 5,716 | 5,790 | -51 | -0.9% | 354,300 |
| 2025/12/23 | 5,977 | 5,985 | 5,803 | 5,841 | -36 | -0.6% | 378,000 |
| 2025/12/22 | 6,061 | 6,090 | 5,866 | 5,877 | -111 | -1.9% | 351,400 |
| 2025/12/19 | 6,000 | 6,060 | 5,955 | 5,988 | +20 | +0.3% | 560,800 |
| 2025/12/18 | 6,045 | 6,100 | 5,853 | 5,968 | -77 | -1.3% | 875,500 |
| 2025/12/17 | 5,982 | 6,056 | 5,910 | 6,045 | +58 | +1% | 788,200 |
| 2025/12/16 | 5,850 | 6,056 | 5,840 | 5,987 | +178 | +3.1% | 912,600 |
| 2025/12/15 | 5,696 | 5,880 | 5,662 | 5,809 | +213 | +3.8% | 662,500 |
| 2025/12/12 | 5,816 | 5,841 | 5,544 | 5,596 | -200 | -3.5% | 919,400 |
| 2025/12/11 | 5,953 | 5,953 | 5,690 | 5,796 | -178 | -3% | 933,500 |
| 2025/12/10 | 5,925 | 6,140 | 5,789 | 5,974 | +49 | +0.8% | 1,548,800 |
| 2025/12/09 | 5,719 | 6,083 | 5,709 | 5,925 | +206 | +3.6% | 3,331,400 |
| 2025/12/08 | 6,160 | 6,529 | 5,434 | 5,719 | +696 | +13.9% | 10,548,200 |
| 2025/12/05 | 5,023 | 5,023 | 5,023 | 5,023 | +700 | +16.2% | 259,700 |
| 2025/12/04 | 4,323 | 4,323 | 4,323 | 4,323 | +700 | +19.3% | 191,500 |
| 2025/12/03 | 3,598 | 3,642 | 3,580 | 3,623 | -19 | -0.5% | 367,700 |
| 2025/12/02 | 3,542 | 3,642 | 3,530 | 3,642 | +89 | +2.5% | 551,500 |
| 2025/12/01 | 3,600 | 3,617 | 3,522 | 3,553 | -80 | -2.2% | 795,600 |
| 2025/11/28 | 3,642 | 3,667 | 3,624 | 3,633 | -15 | -0.4% | 284,800 |
| 2025/11/27 | 3,660 | 3,708 | 3,635 | 3,648 | -53 | -1.4% | 153,800 |
| 2025/11/26 | 3,614 | 3,701 | 3,602 | 3,701 | +99 | +2.7% | 328,900 |
| 2025/11/25 | 3,620 | 3,632 | 3,583 | 3,602 | -25 | -0.7% | 293,600 |
| 2025/11/21 | 3,603 | 3,643 | 3,603 | 3,627 | +3 | +0.1% | 574,500 |
| 2025/11/20 | 3,600 | 3,644 | 3,600 | 3,624 | +4 | +0.1% | 301,600 |
101～
150
件表示中 / 3977件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 413,600円 | +17.1% | +5.9% | 3.00% | 9.20倍 | 0.95倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 154,950円 | +19.1% | -10.3% | 0.00% | 9.03倍 | 2.38倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ロート | 239,800円 | +7.5% | -3.9% | 2.09% | 15.71倍 | 1.79倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
| ツムラ | 379,800円 | +10.9% | -11.3% | 4.16% | 10.80倍 | 0.88倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 東和薬品 | 419,500円 | +11.1% | +6.8% | 2.03% | 9.61倍 | 1.15倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
